English
简体中文
Total: £ 56.28
Published Date: 2026-01-23 | Pages: 116 | Tables: 114 | Medical Care
The global Exosome-mediated Delivery System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
With the advantages of safety, high biocompatibility, high bioavailability, and the ability to penetrate the blood-brain barrier, exosomes have become increasingly promising and potential carriers for RNA drug delivery. Exosomes are small extracellular vesicles released by cells, playing a crucial role in communication between different cell types. Exosomes offer a promising alternative for RNA delivery. Exosomes, unlike other vectors for gene delivery, present unique advantages such that exosomes are a cell-free natural system for ferrying RNA between cells, robust exosomal membrane can protect the RNA/gene of interest from digestion, and exosomes are rapidly taken up by target cells making them a more efficient vehicle for gene delivery. They are generally well-tolerated by the immune system, reducing the risk of adverse reactions. Additionally, they exhibit natural targeting capabilities, allowing them to selectively deliver their cargo to specific cell types or tissues. This ability to target specific cells greatly enhances the therapeutic potential of exosomes for RNA delivery.
The North American market for Exosome-mediated Delivery System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Exosome-mediated Delivery System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Exosome-mediated Delivery System in Gene Therapy is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Exosome-mediated Delivery System include Creative Proteomics, Creative Biogene, Creative Biolabs, Creative Biostructure, Evox Therapeutics Ltd, BOC Sciences, Capricor Therapeutics, ILIAS Biologics Inc., Protheragen-ING, Allife Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Exosome-mediated Delivery System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Exosome-mediated Delivery System. The Exosome-mediated Delivery System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Exosome-mediated Delivery System market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Exosome-mediated Delivery System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Creative Proteomics
Creative Biogene
Creative Biolabs
Creative Biostructure
Evox Therapeutics Ltd
BOC Sciences
Capricor Therapeutics
ILIAS Biologics Inc.
Protheragen-ING
Allife Medicine
EVLiXiR
VesiCURE Therapeutics
Lonza(Codiak Biosciences)
Segment by Type
Proteins
Nucleotides
Small Molecule
Segment by Application
Gene Therapy
Drug Delivery
Vaccine Development
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Exosome-mediated Delivery System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome-mediated Delivery System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Proteins
1.2.3 Nucleotides
1.2.4 Small Molecule
1.3 Market by Application
1.3.1 Global Exosome-mediated Delivery System Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Gene Therapy
1.3.3 Drug Delivery
1.3.4 Vaccine Development
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome-mediated Delivery System Market Perspective (2021–2032)
2.2 Global Exosome-mediated Delivery System Growth Trends by Region
2.2.1 Global Exosome-mediated Delivery System Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Exosome-mediated Delivery System Historic Market Size by Region (2021–2026)
2.2.3 Exosome-mediated Delivery System Forecasted Market Size by Region (2027–2032)
2.3 Exosome-mediated Delivery System Market Dynamics
2.3.1 Exosome-mediated Delivery System Industry Trends
2.3.2 Exosome-mediated Delivery System Market Drivers
2.3.3 Exosome-mediated Delivery System Market Challenges
2.3.4 Exosome-mediated Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exosome-mediated Delivery System Players by Revenue
3.1.1 Global Top Exosome-mediated Delivery System Players by Revenue (2021–2026)
3.1.2 Global Exosome-mediated Delivery System Revenue Market Share by Players (2021–2026)
3.2 Global Top Exosome-mediated Delivery System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Exosome-mediated Delivery System Revenue
3.4 Global Exosome-mediated Delivery System Market Concentration Ratio
3.4.1 Global Exosome-mediated Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome-mediated Delivery System Revenue in 2025
3.5 Global Key Players of Exosome-mediated Delivery System Head Offices and Areas Served
3.6 Global Key Players of Exosome-mediated Delivery System, Products and Applications
3.7 Global Key Players of Exosome-mediated Delivery System, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Exosome-mediated Delivery System Breakdown Data by Type
4.1 Global Exosome-mediated Delivery System Historic Market Size by Type (2021–2026)
4.2 Global Exosome-mediated Delivery System Forecasted Market Size by Type (2027–2032)
5 Exosome-mediated Delivery System Breakdown Data by Application
5.1 Global Exosome-mediated Delivery System Historic Market Size by Application (2021–2026)
5.2 Global Exosome-mediated Delivery System Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Exosome-mediated Delivery System Market Size (2021–2032)
6.2 North America Exosome-mediated Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Exosome-mediated Delivery System Market Size by Country (2021–2026)
6.4 North America Exosome-mediated Delivery System Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exosome-mediated Delivery System Market Size (2021–2032)
7.2 Europe Exosome-mediated Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Exosome-mediated Delivery System Market Size by Country (2021–2026)
7.4 Europe Exosome-mediated Delivery System Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Exosome-mediated Delivery System Market Size (2021–2032)
8.2 Asia-Pacific Exosome-mediated Delivery System Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Exosome-mediated Delivery System Market Size by Region (2021–2026)
8.4 Asia-Pacific Exosome-mediated Delivery System Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Exosome-mediated Delivery System Market Size (2021–2032)
9.2 Latin America Exosome-mediated Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Exosome-mediated Delivery System Market Size by Country (2021–2026)
9.4 Latin America Exosome-mediated Delivery System Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exosome-mediated Delivery System Market Size (2021–2032)
10.2 Middle East & Africa Exosome-mediated Delivery System Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Exosome-mediated Delivery System Market Size by Country (2021–2026)
10.4 Middle East & Africa Exosome-mediated Delivery System Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Proteomics
11.1.1 Creative Proteomics Company Details
11.1.2 Creative Proteomics Business Overview
11.1.3 Creative Proteomics Exosome-mediated Delivery System Introduction
11.1.4 Creative Proteomics Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.1.5 Creative Proteomics Recent Development
11.2 Creative Biogene
11.2.1 Creative Biogene Company Details
11.2.2 Creative Biogene Business Overview
11.2.3 Creative Biogene Exosome-mediated Delivery System Introduction
11.2.4 Creative Biogene Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.2.5 Creative Biogene Recent Development
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Details
11.3.2 Creative Biolabs Business Overview
11.3.3 Creative Biolabs Exosome-mediated Delivery System Introduction
11.3.4 Creative Biolabs Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.3.5 Creative Biolabs Recent Development
11.4 Creative Biostructure
11.4.1 Creative Biostructure Company Details
11.4.2 Creative Biostructure Business Overview
11.4.3 Creative Biostructure Exosome-mediated Delivery System Introduction
11.4.4 Creative Biostructure Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.4.5 Creative Biostructure Recent Development
11.5 Evox Therapeutics Ltd
11.5.1 Evox Therapeutics Ltd Company Details
11.5.2 Evox Therapeutics Ltd Business Overview
11.5.3 Evox Therapeutics Ltd Exosome-mediated Delivery System Introduction
11.5.4 Evox Therapeutics Ltd Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.5.5 Evox Therapeutics Ltd Recent Development
11.6 BOC Sciences
11.6.1 BOC Sciences Company Details
11.6.2 BOC Sciences Business Overview
11.6.3 BOC Sciences Exosome-mediated Delivery System Introduction
11.6.4 BOC Sciences Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.6.5 BOC Sciences Recent Development
11.7 Capricor Therapeutics
11.7.1 Capricor Therapeutics Company Details
11.7.2 Capricor Therapeutics Business Overview
11.7.3 Capricor Therapeutics Exosome-mediated Delivery System Introduction
11.7.4 Capricor Therapeutics Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.7.5 Capricor Therapeutics Recent Development
11.8 ILIAS Biologics Inc.
11.8.1 ILIAS Biologics Inc. Company Details
11.8.2 ILIAS Biologics Inc. Business Overview
11.8.3 ILIAS Biologics Inc. Exosome-mediated Delivery System Introduction
11.8.4 ILIAS Biologics Inc. Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.8.5 ILIAS Biologics Inc. Recent Development
11.9 Protheragen-ING
11.9.1 Protheragen-ING Company Details
11.9.2 Protheragen-ING Business Overview
11.9.3 Protheragen-ING Exosome-mediated Delivery System Introduction
11.9.4 Protheragen-ING Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.9.5 Protheragen-ING Recent Development
11.10 Allife Medicine
11.10.1 Allife Medicine Company Details
11.10.2 Allife Medicine Business Overview
11.10.3 Allife Medicine Exosome-mediated Delivery System Introduction
11.10.4 Allife Medicine Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.10.5 Allife Medicine Recent Development
11.11 EVLiXiR
11.11.1 EVLiXiR Company Details
11.11.2 EVLiXiR Business Overview
11.11.3 EVLiXiR Exosome-mediated Delivery System Introduction
11.11.4 EVLiXiR Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.11.5 EVLiXiR Recent Development
11.12 VesiCURE Therapeutics
11.12.1 VesiCURE Therapeutics Company Details
11.12.2 VesiCURE Therapeutics Business Overview
11.12.3 VesiCURE Therapeutics Exosome-mediated Delivery System Introduction
11.12.4 VesiCURE Therapeutics Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.12.5 VesiCURE Therapeutics Recent Development
11.13 Lonza(Codiak Biosciences)
11.13.1 Lonza(Codiak Biosciences) Company Details
11.13.2 Lonza(Codiak Biosciences) Business Overview
11.13.3 Lonza(Codiak Biosciences) Exosome-mediated Delivery System Introduction
11.13.4 Lonza(Codiak Biosciences) Revenue in Exosome-mediated Delivery System Business (2021–2026)
11.13.5 Lonza(Codiak Biosciences) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Exosome-mediated Delivery System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Proteins
Table 3. Key Players of Nucleotides
Table 4. Key Players of Small Molecule
Table 5. Global Exosome-mediated Delivery System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Exosome-mediated Delivery System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Exosome-mediated Delivery System Market Size by Region (US$ Million), 2021–2026
Table 8. Global Exosome-mediated Delivery System Market Share by Region (2021–2026)
Table 9. Global Exosome-mediated Delivery System Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Exosome-mediated Delivery System Market Share by Region (2027–2032)
Table 11. Exosome-mediated Delivery System Market Trends
Table 12. Exosome-mediated Delivery System Market Drivers
Table 13. Exosome-mediated Delivery System Market Challenges
Table 14. Exosome-mediated Delivery System Market Restraints
Table 15. Global Exosome-mediated Delivery System Revenue by Players (US$ Million), 2021–2026
Table 16. Global Exosome-mediated Delivery System Market Share by Players (2021–2026)
Table 17. Global Top Exosome-mediated Delivery System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Exosome-mediated Delivery System Revenue, 2025
Table 18. Ranking of Global Top Exosome-mediated Delivery System Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Exosome-mediated Delivery System Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Exosome-mediated Delivery System, Headquarters and Area Served
Table 21. Global Key Players of Exosome-mediated Delivery System, Products and Applications
Table 22. Global Key Players of Exosome-mediated Delivery System, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Exosome-mediated Delivery System Market Size by Type (US$ Million), 2021–2026
Table 25. Global Exosome-mediated Delivery System Revenue Market Share by Type (2021–2026)
Table 26. Global Exosome-mediated Delivery System Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Exosome-mediated Delivery System Revenue Market Share by Type (2027–2032)
Table 28. Global Exosome-mediated Delivery System Market Size by Application (US$ Million), 2021–2026
Table 29. Global Exosome-mediated Delivery System Revenue Market Share by Application (2021–2026)
Table 30. Global Exosome-mediated Delivery System Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Exosome-mediated Delivery System Revenue Market Share by Application (2027–2032)
Table 32. North America Exosome-mediated Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Exosome-mediated Delivery System Market Size by Country (US$ Million), 2021–2026
Table 34. North America Exosome-mediated Delivery System Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Exosome-mediated Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Exosome-mediated Delivery System Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Exosome-mediated Delivery System Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Exosome-mediated Delivery System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Exosome-mediated Delivery System Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Exosome-mediated Delivery System Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Exosome-mediated Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Exosome-mediated Delivery System Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Exosome-mediated Delivery System Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Exosome-mediated Delivery System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Exosome-mediated Delivery System Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Exosome-mediated Delivery System Market Size by Country (US$ Million), 2027–2032
Table 47. Creative Proteomics Company Details
Table 48. Creative Proteomics Business Overview
Table 49. Creative Proteomics Exosome-mediated Delivery System Product
Table 50. Creative Proteomics Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 51. Creative Proteomics Recent Development
Table 52. Creative Biogene Company Details
Table 53. Creative Biogene Business Overview
Table 54. Creative Biogene Exosome-mediated Delivery System Product
Table 55. Creative Biogene Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 56. Creative Biogene Recent Development
Table 57. Creative Biolabs Company Details
Table 58. Creative Biolabs Business Overview
Table 59. Creative Biolabs Exosome-mediated Delivery System Product
Table 60. Creative Biolabs Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 61. Creative Biolabs Recent Development
Table 62. Creative Biostructure Company Details
Table 63. Creative Biostructure Business Overview
Table 64. Creative Biostructure Exosome-mediated Delivery System Product
Table 65. Creative Biostructure Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 66. Creative Biostructure Recent Development
Table 67. Evox Therapeutics Ltd Company Details
Table 68. Evox Therapeutics Ltd Business Overview
Table 69. Evox Therapeutics Ltd Exosome-mediated Delivery System Product
Table 70. Evox Therapeutics Ltd Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 71. Evox Therapeutics Ltd Recent Development
Table 72. BOC Sciences Company Details
Table 73. BOC Sciences Business Overview
Table 74. BOC Sciences Exosome-mediated Delivery System Product
Table 75. BOC Sciences Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 76. BOC Sciences Recent Development
Table 77. Capricor Therapeutics Company Details
Table 78. Capricor Therapeutics Business Overview
Table 79. Capricor Therapeutics Exosome-mediated Delivery System Product
Table 80. Capricor Therapeutics Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 81. Capricor Therapeutics Recent Development
Table 82. ILIAS Biologics Inc. Company Details
Table 83. ILIAS Biologics Inc. Business Overview
Table 84. ILIAS Biologics Inc. Exosome-mediated Delivery System Product
Table 85. ILIAS Biologics Inc. Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 86. ILIAS Biologics Inc. Recent Development
Table 87. Protheragen-ING Company Details
Table 88. Protheragen-ING Business Overview
Table 89. Protheragen-ING Exosome-mediated Delivery System Product
Table 90. Protheragen-ING Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 91. Protheragen-ING Recent Development
Table 92. Allife Medicine Company Details
Table 93. Allife Medicine Business Overview
Table 94. Allife Medicine Exosome-mediated Delivery System Product
Table 95. Allife Medicine Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 96. Allife Medicine Recent Development
Table 97. EVLiXiR Company Details
Table 98. EVLiXiR Business Overview
Table 99. EVLiXiR Exosome-mediated Delivery System Product
Table 100. EVLiXiR Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 101. EVLiXiR Recent Development
Table 102. VesiCURE Therapeutics Company Details
Table 103. VesiCURE Therapeutics Business Overview
Table 104. VesiCURE Therapeutics Exosome-mediated Delivery System Product
Table 105. VesiCURE Therapeutics Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 106. VesiCURE Therapeutics Recent Development
Table 107. Lonza(Codiak Biosciences) Company Details
Table 108. Lonza(Codiak Biosciences) Business Overview
Table 109. Lonza(Codiak Biosciences) Exosome-mediated Delivery System Product
Table 110. Lonza(Codiak Biosciences) Revenue in Exosome-mediated Delivery System Business (US$ Million), 2021–2026
Table 111. Lonza(Codiak Biosciences) Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Exosome-mediated Delivery System Picture
Figure 2. Global Exosome-mediated Delivery System Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Exosome-mediated Delivery System Market Share by Type: 2025 vs 2032
Figure 4. Proteins Features
Figure 5. Nucleotides Features
Figure 6. Small Molecule Features
Figure 7. Global Exosome-mediated Delivery System Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Exosome-mediated Delivery System Market Share by Application: 2025 vs 2032
Figure 9. Gene Therapy Case Studies
Figure 10. Drug Delivery Case Studies
Figure 11. Vaccine Development Case Studies
Figure 12. Exosome-mediated Delivery System Report Years Considered
Figure 13. Global Exosome-mediated Delivery System Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Exosome-mediated Delivery System Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Exosome-mediated Delivery System Market Share by Region: 2025 vs 2032
Figure 16. Global Exosome-mediated Delivery System Market Share by Players in 2025
Figure 17. Global Exosome-mediated Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Exosome-mediated Delivery System Revenue in 2025
Figure 19. North America Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Exosome-mediated Delivery System Market Share by Country (2021–2032)
Figure 21. United States Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Exosome-mediated Delivery System Market Share by Country (2021–2032)
Figure 25. Germany Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Exosome-mediated Delivery System Market Share by Region (2021–2032)
Figure 33. China Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Exosome-mediated Delivery System Market Share by Country (2021–2032)
Figure 41. Mexico Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Exosome-mediated Delivery System Market Share by Country (2021–2032)
Figure 45. Israel Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Exosome-mediated Delivery System Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Creative Proteomics Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 49. Creative Biogene Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 50. Creative Biolabs Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 51. Creative Biostructure Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 52. Evox Therapeutics Ltd Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 53. BOC Sciences Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 54. Capricor Therapeutics Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 55. ILIAS Biologics Inc. Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 56. Protheragen-ING Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 57. Allife Medicine Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 58. EVLiXiR Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 59. VesiCURE Therapeutics Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 60. Lonza(Codiak Biosciences) Revenue Growth Rate in Exosome-mediated Delivery System Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
